Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor.
about
Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transferGenetic PEGylationSortase-catalyzed transformations that improve the properties of cytokinesEngineering superactive granulocyte macrophage colony-stimulating factor transferrin fusion proteins as orally-delivered candidate agents for treating neurodegenerative disease.Neutrophil biology and the next generation of myeloid growth factors.Cytokine refacing effect reduces granulocyte macrophage colony-stimulating factor susceptibility to antibody neutralization.PRINT: A Protein Bioconjugation Method with Exquisite N-terminal Specificity.Agents under investigation for the treatment and prevention of neutropenia.PEGylated G-CSF (BBT-015), GM-CSF (BBT-007), and IL-11 (BBT-059) analogs enhance survival and hematopoietic cell recovery in a mouse model of the hematopoietic syndrome of the acute radiation syndrome.Site-specific PEGylation enhances the pharmacokinetic properties and antitumor activity of interferon beta-1b.PEGylation and its impact on the design of new protein-based medicines.Development of Peptide Vaccines in Dengue.In silico designing of a new cysteine analogue of hirudin variant 3 for site specific PEGylation.Allylic selenosulfide rearrangement: a method for chemical ligation to cysteine and other thiols.Two site genetic incorporation of varying length polyethylene glycol into the backbone of one peptide.PEGylation and Dimerization of Expressed Proteins under Near Equimolar Conditions with Potassium 2-Pyridyl Acyltrifluoroborates.Biosynthetic-Synthetic Polymer Conjugates
P2860
Q33296224-4C53540C-028A-4676-9659-88C923E7E80DQ34474297-340858A9-3268-446B-A26E-7680904A686AQ34602642-84B7D4D3-5E21-4860-A641-182491877C10Q35571088-AA0121D7-4C8A-4CD2-BC7C-117870323234Q35653712-43A7F348-FB69-4D8A-A0B4-9089638F4EDBQ36130660-20FABE63-F458-461B-8F04-8FB08035EBAEQ36383059-2A3E4EAE-6FAE-42A5-A0F0-884B4E13C780Q36985881-468A72C6-0655-4CF8-B847-747CF406C534Q37349170-A39A433C-6A90-41B4-9316-EB285CFC833AQ37404242-1CEA8F85-FF48-402B-A5E8-057BF7E75CFEQ38269324-E1A921A5-2585-4340-9E84-3E6DD953F216Q40038715-E7C02297-3895-4248-9F6A-D5E5E54F029AQ41951405-FCC737AF-788B-4DD7-AB96-D6B59A14EEE5Q43157115-B7DF3677-C127-431C-B1A4-9F5B886E640BQ46690185-73871D73-CDE4-4A8C-B31F-19B5BF771A87Q55057051-DB12B252-FA86-496C-A5C0-3204EF49B50FQ57373258-74429447-A40F-4DAE-9766-D1DA094E2C2F
P2860
Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Site-specific PEGylation of en ...... age colony-stimulating factor.
@ast
Site-specific PEGylation of en ...... age colony-stimulating factor.
@en
Site-specific PEGylation of en ...... age colony-stimulating factor.
@nl
type
label
Site-specific PEGylation of en ...... age colony-stimulating factor.
@ast
Site-specific PEGylation of en ...... age colony-stimulating factor.
@en
Site-specific PEGylation of en ...... age colony-stimulating factor.
@nl
prefLabel
Site-specific PEGylation of en ...... age colony-stimulating factor.
@ast
Site-specific PEGylation of en ...... age colony-stimulating factor.
@en
Site-specific PEGylation of en ...... age colony-stimulating factor.
@nl
P2093
P2860
P356
P1476
Site-specific PEGylation of en ...... age colony-stimulating factor.
@en
P2093
Daniel H Doherty
Darin J Smith
Elizabeth A Chlipala
George N Cox
Jennifer M Hughes
Mary S Rosendahl
P2860
P304
P356
10.1021/BC050172R
P577
2005-09-01T00:00:00Z